Julie A. Hanson

TL;DR: It is concluded that transplantation of a marginal kidney is associated with a significant survival benefit when compared with maintenance dialysis and the average increase in life expectancy for MDK recipients compared with the WLD cohort was 5 yr, although this benefit varied from 3 to 10 yr depending on the recipient's characteristics.

TL;DR: Although DWGF is a major cause of graft loss, the risk has declined substantially since 1990 and attention to atherosclerotic risk factors may be the most important challenge to further improve the longevity of patients with successful renal transplants.

TL;DR: The hypothesis that patients who reach end-stage renal disease should receive a renal transplant as early as possible in order to enhance their chances of long-term survival is supported.

TL;DR: Mycophenolate Mofetil therapy decreased the relative risk for development of chronic allograft failure (CAF) by 27% and was independent of its outcome on acute rejection.

TL;DR: Among patients with type 1 DM with end-stage nephropathy, SPK transplantation before the age of 50 years was associated with long-term improvement in survival compared to solitary cadaveric renal transplantation or dialysis.